Reasons to Invest
• First MGO honey-based wound dressing patented formulations with anticipated FDA microbial claim
• Our advanced wound care dressings will address the antimicrobial resistance (AMR) crisis
• Our bioactive buckwheat honey products promote faster and healthier healing
The Problems
Anti-microbial Resistance (AMR) Crisis
* Anti-microbial infections currently kill 700,000+ people
* Globally projected to increase to 10 million people per year by 2050
Diabetic Foot Ulcers (DFU)
* Estimated 26 million patients develop DFUs globally
* Last 13 months and recur in up to 70% of patients
* Results in 15% requiring amputations with 47% ending in death
Radiation, Chemical and Thermal Burns
* Few effective therapies for radiotherapy, laser therapy and minor thermal burns
* Of the 3 million patients receiving radiation, 85% experience moderate to severe skin reactions
The Solutions
Anti-microbial Resistance (AMR) Crisis
* Our BEECure™ M patented formulation reduces microbial growth
Diabetic Foot Ulcers (DFU)
Radiation, Chemical and Thermal Burns